Answers are grounded in this paper and cite their sources.
Editorial comments on therapy options for coccidioidal meningitis, highlighting amphotericin use in severe cases.
Summary An editorial commentary on management options for coccidioidal meningitis with recent increasing concerns about fluconazole failure. We favor the use of mold-active azoles with mild symptoms of relapse or progression, and initiation of intrathecal amphotericin B for severe disease.
No takes yet. Share an insight, caveat, or question.
Malhotra et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: